5-alpha reductase inhibitors reduce prostate cancer risk, but not all experts are ready to support their chemopreventive role

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2010年 / 45卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [21] Chemoprevention of prostate cancer - the role of 5 alpha reductase inhibitors
    Parekh, D.
    [J]. EJC SUPPLEMENTS, 2010, 8 (02): : 4 - 4
  • [22] PROSTATE BIOPSY AFTER TREATMENT WITH 5-ALPHA REDUCTASE INHIBITORS MARKEDLY ENHANCES PROSTATE CANCER DETECTION
    Kaplan, Steven
    Lee, Richard
    Chung, Doreen E.
    Scherr, Douglas
    Te, Alexis
    Vaughan, E. Darracott
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E773 - E773
  • [23] Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    Stephanie R. Earnshaw
    Cheryl L. McDade
    Libby K. Black
    Christopher F. Bell
    Michael W. Kattan
    [J]. PharmacoEconomics, 2010, 28 : 489 - 505
  • [24] INCIDENCE OF FALSE NEGATIVE PROSTATE CANCER SCREENING IN PATIENT TAKING 5-ALPHA REDUCTASE INHIBITORS
    Fram, Ethan
    Maria, Pedro
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1033 - E1034
  • [25] Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Black, Libby K.
    Bell, Christopher F.
    Kattan, Michael W.
    [J]. PHARMACOECONOMICS, 2010, 28 (06) : 489 - 505
  • [26] THE RISK OF FRACTURES WITH ALPHA BLOCKERS AND 5-ALPHA REDUCTASE INHIBITORS IN BENIGN PROSTATE HYPERPLASIA: A META-ANALYSIS
    Lim, S.
    Laengvejkal, P.
    Nugent, K.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 457 - 457
  • [27] Role of 5 alpha-reductase inhibitors in the management of prostate cancer
    Hudak, Steven J.
    Hernandez, Javier
    Thompson, Ian M.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 425 - 431
  • [28] PROSTATE HEALTH INDEX PREDICTS UPGRADING OF MEN ON 5-ALPHA REDUCTASE INHIBITORS
    Crawford, E. David
    Arangua, Paul
    Jones, Clifford
    Poage, Wendy
    Stone, Nelson
    La Rosa, Francisco G.
    Loeb, Stacy
    Werahera, Priya N.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E56 - E56
  • [29] The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
    Goldenberg, Larry
    So, Alan
    Fleshner, Neil
    Rendon, Ricardo
    Drachenberg, Darrel
    Elhilali, Mostafa
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (03): : S109 - S114
  • [30] Differential expression and quantitation of 5-alpha reductase (5αR) in prostate cancer
    Chikkamuniyappa, S
    McMasters, R
    Ghosh, P
    Thompson, I
    Leach, R
    Troyer, D
    [J]. MODERN PATHOLOGY, 2005, 18 : 133A - 133A
12345